Dreyer Scott 4/A
4/A · COLLEGIUM PHARMACEUTICAL, INC · Filed Mar 18, 2025
Insider Transaction Report
Form 4/AAmended
Dreyer Scott
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-03-11$30.00/sh−15,387$461,672→ 126,676 total
Footnotes (3)
- [F1]The original Form 4 filed on March 13, 2025 on behalf of the Reporting Person inadvertently reported the incorrect transaction date. As reported in this amendment, the correct transaction date is March 11, 2025.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.
- [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.